Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on Novartis AG. We currently have 60 research reports from 8 professional analysts.
Date | Source | Announcement |
---|---|---|
29Jan20 06:00 | GNW | Novartis delivered strong sales growth, margin expansion and breakthrough innovation launching five NMEs in 2019 |
06Jan20 06:00 | GNW | Novartis completes tender offer for all outstanding shares of The Medicines Company |
16Dec19 06:15 | GNW | Novartis provides update on LUSTER Phase III studies in patients with uncontrolled GINA 4/5 asthma |
05Dec19 06:00 | GNW | Novartis tender offer for The Medicines Company commences |
24Nov19 20:00 | GNW | Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death |
15Nov19 20:06 | GNW | New Novartis medicine Adakveo® (crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease |
01Nov19 06:15 | GNW | Novartis Cosentyx® shows encouraging results versus Humira®* from first-of-its-kind head-to-head trial in psoriatic arthritis |
Share: